Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close?

Jonel Trebicka1

  • 1Department of Internal Medicine I, University of Bonn, Bonn, Germany; Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark.

Journal of Hepatology
|December 17, 2016
PubMed

Insights

Early transjugular intrahepatic portosystemic shunt (TIPS) placement may improve survival for cirrhosis patients with complications. Careful patient selection and new biomarkers are crucial for optimizing TIPS outcomes.

Area of Science:

  • Hepatology
  • Interventional Radiology
  • Gastroenterology

Background:

  • Transjugular intrahepatic portosystemic shunt (TIPS) manages cirrhosis complications like variceal bleeding and ascites.
  • TIPS carries risks including liver failure, hepatic encephalopathy (HE), and cardiac issues.
  • Early intervention with TIPS may mitigate adverse outcomes in decompensated cirrhosis.

Purpose of the Study:

  • To evaluate the impact of early TIPS placement on survival in patients with cirrhosis complications.
  • To explore the role of TIPS in preventing inflammatory and bacterial translocation responses.
  • To assess the benefit of early TIPS in managing refractory ascites and preventing acute kidney injury (AKI).

Main Methods:

  • Review of current literature and clinical practice regarding TIPS indications and timing.
  • Analysis of the pathophysiological mechanisms linking TIPS to patient outcomes.
  • Discussion of emerging biomarkers for patient selection and outcome prediction.

Main Results:

  • Early TIPS improves survival in decompensated cirrhosis patients with variceal bleeding.
  • Timely TIPS placement in refractory ascites may prevent AKI and hepatorenal syndrome (HRS).
  • The role of TIPS in portal vein thrombosis and spontaneous shunts requires further investigation.

Conclusions:

  • Careful patient selection is paramount for successful TIPS procedures.
  • Early application of TIPS can enhance survival and prevent severe complications.
  • Novel biomarkers assessing inflammation and bacterial translocation could refine patient stratification for TIPS.

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.1K
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
3.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
595
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
637